Certified by Founder Lodge
Loyal / Cellular Longevity
United States - San Francisco, CA
START UP
1 Disclosed Funding Rounds $45,000,000
0 Participating Investments
-
Founded date
2020
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Loyal is part of Cellular Longevity, a company working to develop the first drugs explicitly intended to extend healthspan and lifespan — first in dogs, and then in humans, too.
By quanti
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| March, 22 ,2024 | Series B | $45,000,000 |
Bain Capital Ventures
Khosla Ventures
Collaborative Fund
BoxGroup
Quiet Capital
First Round Capital
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
ArkeaBio™ | $26,500,000 | (May 10, 2024)
Electricity Maps | $5,390,775 | (May 10, 2024)
CoverTree | $13,000,000 | (May 10, 2024)
Sift Healthcare | $20,000,000 | (May 10, 2024)
Bluejay Therapeutics | $182,000,000 | (May 10, 2024)
